TNFSF10 and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been investigated as one of the most promising anticancer candidates in cancer research because it preferentially induces apoptosis in cancer cells but not in normal cells [3, 4].